Galvin James E, Tolea Magdalena I, Chrisphonte Stephanie
Department of Neurology, Comprehensive Center for Brain Health, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
PLoS One. 2020 Jul 1;15(7):e0235534. doi: 10.1371/journal.pone.0235534. eCollection 2020.
Alzheimer's disease and related dementias (ADRD) and mild cognitive impairment (MCI) are often under-recognized in the community. MCI/ADRD screening could offer benefits such as early treatment, research participation, lifestyle modification, and advanced care planning. To date, there are no clear guidelines regarding the benefits vs. harms of dementia screening or whether a dementia screening program could be successful.
A community-based study was conducted to evaluate an MCI/ADRD screening program and determine what older adults would do with the information. Measures of cognition, physical health, functionality, and mood were collected. Participants met with a health professional, were given screening results with recommendations, and then contacted 60 days later to determine what was done with the results. Logistic regression models were used to build predictive models.
Participants (n = 288) had a mean age of 71.5±8.3y, mean education of 13.3±4.8y, and were 70% female, 67% White, 26% African American, and 48% Hispanic. After 60 days, 75% of participants were re-contacted; 54% shared results with family, 33% shared results with health care providers (HCPs), and 52% initiated behavioral change. Among participants sharing results with HCPs, 51% reported HCPs did not follow-up on the results, and 18% that HCPs did not show any interest in the screening visit or its results. Predictors of sharing results with HCPs were elevated hemoglobin A1C (OR = 1.85;95%CI:1.19-2.88), uncontrolled hypertension (OR = 2.73;95%CI:1.09-6.83), and mobility issues (OR = 2.43;95%CI: 1.93-5.54). Participant behavioral changes included lifestyle modification (58%), social engagement (10%), cognitive stimulation (5%), and advanced care planning (4%). The most significant predictors of sharing with family were better overall mental health (OR = 0.19; 95%CI: 0.06-0.59) and better physical function (OR = 0.38; 95%CI: 0.17-0.81).
MCI/ADRD screening was well-received by a diverse community sample. Participants showed interest in sharing the results with their family and HCPs and many attempted behavioral change. While HCPs did not always act on screening results, 25% ordered further testing and evaluation. Efforts need to be directed toward (1) increasing self-efficacy of older adults to discuss screening results with their HCPs, and (2) educating HCPs on the value of early detection of MCI/ADRD. Community dementia screening programs can increase MCI/ADRD detection and improve patient-centered outcomes and medical decision-making.
阿尔茨海默病及相关痴呆症(ADRD)和轻度认知障碍(MCI)在社区中常常未得到充分认识。MCI/ADRD筛查可能带来诸多益处,如早期治疗、参与研究、改变生活方式以及进行高级护理规划。迄今为止,关于痴呆症筛查的利弊以及痴呆症筛查项目是否能够成功,尚无明确的指导方针。
开展了一项基于社区的研究,以评估MCI/ADRD筛查项目,并确定老年人会如何处理筛查信息。收集了认知、身体健康、功能和情绪方面的测量数据。参与者与一名健康专业人员会面,获得带有建议的筛查结果,然后在60天后进行回访,以确定他们如何处理这些结果。使用逻辑回归模型构建预测模型。
参与者(n = 288)的平均年龄为71.5±8.3岁,平均受教育年限为13.3±4.8年,女性占70%,白人占67%,非裔美国人占26%,西班牙裔占48%。60天后,75%的参与者接受了回访;54%的人将结果告知家人,33%的人将结果告知医疗保健提供者(HCP),52%的人开始改变行为。在将结果告知HCP的参与者中,51%的人表示HCP未对结果进行跟进,18%的人表示HCP对筛查就诊或结果不感兴趣。与HCP分享结果的预测因素包括糖化血红蛋白A1C升高(OR = 1.85;95%CI:1.19 - 2.88)、未控制的高血压(OR = 2.73;95%CI:1.09 - 6.83)以及行动不便问题(OR = 2.43;95%CI:1.93 - 5.54)。参与者的行为改变包括改变生活方式(58%)、社交参与(10%)、认知刺激(5%)和进行高级护理规划(4%)。与家人分享结果的最显著预测因素是整体心理健康状况较好(OR = 0.19;95%CI:0.06 - 0.59)和身体功能较好(OR = 0.38;95%CI:0.17 - 0.81)。
MCI/ADRD筛查受到了多样化社区样本的好评。参与者表现出与家人和HCP分享结果的意愿,许多人尝试改变行为。虽然HCP并非总是根据筛查结果采取行动,但25%的人安排了进一步的检测和评估。需要努力(1)提高老年人与HCP讨论筛查结果的自我效能,以及(2)让HCP了解早期检测MCI/ADRD的价值。社区痴呆症筛查项目可以提高MCI/ADRD的检测率,并改善以患者为中心的结局和医疗决策。